Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34

ABSTRACT P34 is an antimicrobial peptide produced by Bacillus sp. P34, isolated from the intestinal contents of a fish from the Amazon basin. This peptide showed antibacterial properties against Gram-positive and Gram-negative bacteria and was characterized as a bacteriocin like substance. It was demonstrated that the peptide P34 exhibited antiviral activity against feline herpesvirus type 1 in vitro. The aim of this work was to evaluate P34 for its antiviral properties in vitro, using RK 13 cells, against the equine arteritis virus, since it has no specific treatment and a variable proportion of stallions may become persistently infected. The results obtained show that P34 exerts antiviral and virucidal activities against equine arteritis virus, probably in the viral envelope. The antiviral assays performed showed that P34 reduces significantly the viral titers of treated cell cultures. The mechanism of action of P34 seems to be time/temperature-dependent. This peptide tends to be a promising antiviral compound for the prevention and treatment of arteriviral infections since it has a high therapeutic index. However, more detailed studies must be performed to address the exact step of viral infection where P34 acts, in order to use this peptide as an antiviral drug in vivo in the future.

Saved in:
Bibliographic Details
Main Authors: Silva,D. Scopel e, Castro,C.C., Silva e Silva,F., Costa,G.A., Soares,M.P., Vargas,G.D., Fischer,G., Lima,M., Brandelli,A., Motta,A.S., Hübner,S.O.
Format: Digital revista
Language:English
Published: Universidade Federal de Minas Gerais, Escola de Veterinária 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352017000300535
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-09352017000300535
record_format ojs
spelling oai:scielo:S0102-093520170003005352017-07-07Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34Silva,D. Scopel eCastro,C.C.Silva e Silva,F.Costa,G.A.Soares,M.P.Vargas,G.D.Fischer,G.Lima,M.Brandelli,A.Motta,A.S.Hübner,S.O. equine arteritis virus antiviral therapy antimicrobial peptide virucidal activity ABSTRACT P34 is an antimicrobial peptide produced by Bacillus sp. P34, isolated from the intestinal contents of a fish from the Amazon basin. This peptide showed antibacterial properties against Gram-positive and Gram-negative bacteria and was characterized as a bacteriocin like substance. It was demonstrated that the peptide P34 exhibited antiviral activity against feline herpesvirus type 1 in vitro. The aim of this work was to evaluate P34 for its antiviral properties in vitro, using RK 13 cells, against the equine arteritis virus, since it has no specific treatment and a variable proportion of stallions may become persistently infected. The results obtained show that P34 exerts antiviral and virucidal activities against equine arteritis virus, probably in the viral envelope. The antiviral assays performed showed that P34 reduces significantly the viral titers of treated cell cultures. The mechanism of action of P34 seems to be time/temperature-dependent. This peptide tends to be a promising antiviral compound for the prevention and treatment of arteriviral infections since it has a high therapeutic index. However, more detailed studies must be performed to address the exact step of viral infection where P34 acts, in order to use this peptide as an antiviral drug in vivo in the future.info:eu-repo/semantics/openAccessUniversidade Federal de Minas Gerais, Escola de VeterináriaArquivo Brasileiro de Medicina Veterinária e Zootecnia v.69 n.3 20172017-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352017000300535en10.1590/1678-4162-9140
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Silva,D. Scopel e
Castro,C.C.
Silva e Silva,F.
Costa,G.A.
Soares,M.P.
Vargas,G.D.
Fischer,G.
Lima,M.
Brandelli,A.
Motta,A.S.
Hübner,S.O.
spellingShingle Silva,D. Scopel e
Castro,C.C.
Silva e Silva,F.
Costa,G.A.
Soares,M.P.
Vargas,G.D.
Fischer,G.
Lima,M.
Brandelli,A.
Motta,A.S.
Hübner,S.O.
Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
author_facet Silva,D. Scopel e
Castro,C.C.
Silva e Silva,F.
Costa,G.A.
Soares,M.P.
Vargas,G.D.
Fischer,G.
Lima,M.
Brandelli,A.
Motta,A.S.
Hübner,S.O.
author_sort Silva,D. Scopel e
title Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
title_short Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
title_full Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
title_fullStr Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
title_full_unstemmed Inhibition of equine arteritis virus by an antimicrobial peptide produced by Bacillus sp. P34
title_sort inhibition of equine arteritis virus by an antimicrobial peptide produced by bacillus sp. p34
description ABSTRACT P34 is an antimicrobial peptide produced by Bacillus sp. P34, isolated from the intestinal contents of a fish from the Amazon basin. This peptide showed antibacterial properties against Gram-positive and Gram-negative bacteria and was characterized as a bacteriocin like substance. It was demonstrated that the peptide P34 exhibited antiviral activity against feline herpesvirus type 1 in vitro. The aim of this work was to evaluate P34 for its antiviral properties in vitro, using RK 13 cells, against the equine arteritis virus, since it has no specific treatment and a variable proportion of stallions may become persistently infected. The results obtained show that P34 exerts antiviral and virucidal activities against equine arteritis virus, probably in the viral envelope. The antiviral assays performed showed that P34 reduces significantly the viral titers of treated cell cultures. The mechanism of action of P34 seems to be time/temperature-dependent. This peptide tends to be a promising antiviral compound for the prevention and treatment of arteriviral infections since it has a high therapeutic index. However, more detailed studies must be performed to address the exact step of viral infection where P34 acts, in order to use this peptide as an antiviral drug in vivo in the future.
publisher Universidade Federal de Minas Gerais, Escola de Veterinária
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352017000300535
work_keys_str_mv AT silvadscopele inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT castrocc inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT silvaesilvaf inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT costaga inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT soaresmp inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT vargasgd inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT fischerg inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT limam inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT brandellia inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT mottaas inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
AT hubnerso inhibitionofequinearteritisvirusbyanantimicrobialpeptideproducedbybacillusspp34
_version_ 1756395716097343488